KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Thermo Fisher Scientific (TMO) Gross Profit (2016 - 2025)

Thermo Fisher Scientific's Gross Profit history spans 17 years, with the latest figure at $8.5 billion for Q4 2025.

  • For the quarter ending Q4 2025, Gross Profit rose 4.13% year-over-year to $8.5 billion, compared with a TTM value of $31.3 billion through Dec 2025, up 2.74%, and an annual FY2025 reading of $31.2 billion, up 3.06% over the prior year.
  • Gross Profit for Q4 2025 was $8.5 billion at Thermo Fisher Scientific, up from $7.9 billion in the prior quarter.
  • The five-year high for Gross Profit was $14.7 billion in Q4 2021, with the low at $5.9 billion in Q3 2021.
  • Average Gross Profit over 5 years is $8.1 billion, with a median of $7.5 billion recorded in 2023.
  • Year-over-year, Gross Profit soared 37.05% in 2022 and then plummeted 30.67% in 2023.
  • Tracing TMO's Gross Profit over 5 years: stood at $14.7 billion in 2021, then fell by 29.81% to $10.3 billion in 2022, then tumbled by 30.67% to $7.2 billion in 2023, then grew by 14.02% to $8.2 billion in 2024, then increased by 4.13% to $8.5 billion in 2025.
  • Per Business Quant, the three most recent readings for TMO's Gross Profit are $8.5 billion (Q4 2025), $7.9 billion (Q3 2025), and $7.6 billion (Q2 2025).